Detalhe da pesquisa
1.
Synthesis and biological study of class I selective HDAC inhibitors with NO releasing activity.
Bioorg Chem
; 104: 104235, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32896808
2.
Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry.
Bioorg Med Chem
; 26(12): 3145-3157, 2018 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29859750
3.
Design, synthesis and anti-tumor activity study of novel histone deacetylase inhibitors containing isatin-based caps and o-phenylenediamine-based zinc binding groups.
Bioorg Med Chem
; 25(12): 2981-2994, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28511906
4.
Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors.
Eur J Med Chem
; 150: 282-291, 2018 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29533873
5.
Nitric oxide donor hybrid compounds as promising anticancer agents.
Drug Discov Ther
; 10(6): 276-284, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27990006
6.
Selective HDAC inhibitors with potent oral activity against leukemia and colorectal cancer: Design, structure-activity relationship and anti-tumor activity study.
Eur J Med Chem
; 134: 185-206, 2017 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28415009